Logo.png
BioRestorative Therapies Enters into Letter of Intent with PRC Clinical
November 19, 2021 06:00 ET | BioRestorative Therapies, Inc
PRC Clinical to Provide Start-up CRO Services for BRTX-100 Phase 2 Clinical Trial MELVILLE, N.Y., Nov. 19, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company" or...
BRT-logo-final.png
BioRestorative Therapies Announces Nomination of Two New Members to the Board of Directors
October 26, 2021 08:00 ET | BioRestorative Therapies, Inc
MELVILLE, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BRT-logo-final.png
BioRestorative Therapies Receives Patent in Australia Related to its Off-the-Shelf ThermoStem® Program
September 02, 2021 09:00 ET | BioRestorative Therapies, Inc
Issued Patent Grants Protection for an Implantable Scaffold using Brown Adipose Derived Stem Cells and Methods of Use MELVILLE, N.Y., Sept. 02, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies,...
BRT-logo-final.png
BioRestorative Therapies Announces Filing of Registration Statement for Proposed Public Offering
August 09, 2021 11:58 ET | BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 09, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
BRT-logo-final.png
BioRestorative Therapies Expanding its Cell Therapy Manufacturing Facility
May 10, 2021 06:00 ET | BioRestorative Therapies, Inc
MELVILLE, N.Y., May 10, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...